1436 related articles for article (PubMed ID: 30926472)
1. Advances in CRISPR-Cas systems for RNA targeting, tracking and editing.
Wang F; Wang L; Zou X; Duan S; Li Z; Deng Z; Luo J; Lee SY; Chen S
Biotechnol Adv; 2019; 37(5):708-729. PubMed ID: 30926472
[TBL] [Abstract][Full Text] [Related]
2. Insights Gained from RNA Editing Targeted by the CRISPR-Cas13 Family.
Liu L; Pei DS
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232699
[TBL] [Abstract][Full Text] [Related]
3. Applications of CRISPR/Cas13-Based RNA Editing in Plants.
Kavuri NR; Ramasamy M; Qi Y; Mandadi K
Cells; 2022 Aug; 11(17):. PubMed ID: 36078073
[TBL] [Abstract][Full Text] [Related]
4. RNA-Targeting CRISPR-Cas Systems and Their Applications.
Burmistrz M; Krakowski K; Krawczyk-Balska A
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046217
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-Based Technologies: Impact of RNA-Targeting Systems.
Terns MP
Mol Cell; 2018 Nov; 72(3):404-412. PubMed ID: 30388409
[TBL] [Abstract][Full Text] [Related]
6. Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR-Cas Systems.
O'Connell MR
J Mol Biol; 2019 Jan; 431(1):66-87. PubMed ID: 29940185
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
[TBL] [Abstract][Full Text] [Related]
8.
Ma X; Wong AS; Tam HY; Tsui SY; Chung DL; Feng B
Zool Res; 2018 Mar; 39(2):58-71. PubMed ID: 29515088
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cas13 Precision Transcriptome Engineering in Cancer.
Granados-Riveron JT; Aquino-Jarquin G
Cancer Res; 2018 Aug; 78(15):4107-4113. PubMed ID: 30021724
[TBL] [Abstract][Full Text] [Related]
10. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.
Xu J; Ren X; Sun J; Wang X; Qiao HH; Xu BW; Liu LP; Ni JQ
J Genet Genomics; 2015 Apr; 42(4):141-9. PubMed ID: 25953352
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9-mediated genome editing in sea urchins.
Lin CY; Oulhen N; Wessel G; Su YH
Methods Cell Biol; 2019; 151():305-321. PubMed ID: 30948015
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas Systems towards Next-Generation Biosensing.
Li Y; Li S; Wang J; Liu G
Trends Biotechnol; 2019 Jul; 37(7):730-743. PubMed ID: 30654914
[TBL] [Abstract][Full Text] [Related]
13. Cas13d: A New Molecular Scissor for Transcriptome Engineering.
Gupta R; Ghosh A; Chakravarti R; Singh R; Ravichandiran V; Swarnakar S; Ghosh D
Front Cell Dev Biol; 2022; 10():866800. PubMed ID: 35433685
[TBL] [Abstract][Full Text] [Related]
14. CRISPR technology to combat plant RNA viruses: A theoretical model for Potato virus Y (PVY) resistance.
Hameed A; Shan-E-Ali Zaidi S; Sattar MN; Iqbal Z; Tahir MN
Microb Pathog; 2019 Aug; 133():103551. PubMed ID: 31125685
[TBL] [Abstract][Full Text] [Related]
15. Discovery, classification and application of the CPISPR-Cas13 system.
Nie X; Wang D; Pan Y; Hua Y; Lü P; Yang Y
Technol Health Care; 2024; 32(2):525-544. PubMed ID: 37545273
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
Hong KQ; Liu DY; Chen T; Wang ZW
World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
[TBL] [Abstract][Full Text] [Related]
17. The multiplexed CRISPR targeting platforms.
Cao J; Xiao Q; Yan Q
Drug Discov Today Technol; 2018 Aug; 28():53-61. PubMed ID: 30205881
[TBL] [Abstract][Full Text] [Related]
18. Functional Features and Current Applications of the RNA-Targeting Type VI CRISPR-Cas Systems.
Perčulija V; Lin J; Zhang B; Ouyang S
Adv Sci (Weinh); 2021 Jul; 8(13):2004685. PubMed ID: 34254038
[TBL] [Abstract][Full Text] [Related]
19. Mini review: genome and transcriptome editing using CRISPR-cas systems for haematological malignancy gene therapy.
Elliott EK; Haupt LM; Griffiths LR
Transgenic Res; 2021 Apr; 30(2):129-141. PubMed ID: 33609253
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-Cas13 technology portfolio and alliance with other genetic tools.
Wu S; Tian P; Tan T
Biotechnol Adv; 2022 Dec; 61():108047. PubMed ID: 36208845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]